Rodríguez José Juan Viña, Santolaria Francisco, Martínez-Riera Antonio, González-Reimers Emilio, de la Vega Prieto María José, Valls María Remedios Alemán, Gaspar Melchor Rodríguez
Servicio de Medicina Interna, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife 38320, Spain.
Metabolism. 2006 May;55(5):620-7. doi: 10.1016/j.metabol.2005.12.009.
Serum homocysteine levels, which increase with age, are now recognized as a vascular risk factor and are related to the development of heart failure and dementia in the elderly. However, relatively low serum homocysteine levels have also been reported to be an adverse prognostic factor in dialysis patients. The objective of the study was to analyze the prevalence, clinical significance, and prognostic value of serum homocysteine levels in patients older than 65 years, admitted to a general internal medicine hospitalization unit. We studied 337 hospitalized patients, 184 males and 153 females, aged 77.2+/-0.4 years, whose admission was not determined by an acute vascular event. We recorded past vascular events and vascular risk factors. We determined the body mass index (weight in kilograms divided by the square of height in meters), and cholesterol, triglyceride, folate, vitamin B12, and homocysteine levels. We also studied 36 control subjects (18 males and 18 females) of similar age. After discharge, we assessed the survival status of 301 patients by telephone recall. Survival curves were plotted by the method of Kaplan and Meier. Median survival was 1186 days. The 15th (9.6 micromol/L) and 50th (14.4 micromol/L) percentiles, as the lowest and highest cut-off points, were empirically defined as those related to a shorter survival. Serum homocysteine concentration was significantly positively correlated with age and serum creatinine and albumin concentrations, and negatively correlated with serum cobalamin and folate concentrations. The average serum homocysteine concentration for the patients group, as a whole, was 16.5+/-0.5 micromol/L, not significantly different from the control group, but with a much greater dispersion, as patients with congestive heart failure or cognitive impairment had higher serum homocysteine concentrations, and patients with sepsis, leukocytosis, and hypoalbuminemia had lower concentrations. Malnutrition was associated both with abnormally high and low homocysteine concentrations, and abnormally low and abnormally high homocysteine concentrations were both associated with higher mortality. In conclusion, low homocysteine levels in elderly non-vitamin-supplemented hospitalized patients should not be interpreted as a protective factor in some individuals. Instead, it may be considered as an effect of an inflammatory-malnutrition process associated with a poor prognosis.
血清同型半胱氨酸水平随年龄增长而升高,现在被认为是一种血管危险因素,与老年人心力衰竭和痴呆的发生有关。然而,也有报道称相对较低的血清同型半胱氨酸水平是透析患者的不良预后因素。本研究的目的是分析入住普通内科住院病房的65岁以上患者血清同型半胱氨酸水平的患病率、临床意义及预后价值。我们研究了337例住院患者,其中男性184例,女性153例,年龄77.2±0.4岁,其入院并非由急性血管事件决定。我们记录了既往血管事件和血管危险因素。我们测定了体重指数(体重千克数除以身高米数的平方)、胆固醇、甘油三酯、叶酸、维生素B12和同型半胱氨酸水平。我们还研究了36名年龄相仿的对照者(男性18例,女性18例)。出院后,我们通过电话随访评估了301例患者的生存状况。采用Kaplan-Meier法绘制生存曲线。中位生存期为1186天。第15百分位数(9.6微摩尔/升)和第50百分位数(14.4微摩尔/升),作为最低和最高截断点,根据经验定义为与较短生存期相关的数值。血清同型半胱氨酸浓度与年龄、血清肌酐和白蛋白浓度呈显著正相关,与血清钴胺素和叶酸浓度呈负相关。患者组总体血清同型半胱氨酸平均浓度为16.5±0.5微摩尔/升,与对照组无显著差异,但离散度大得多,因为充血性心力衰竭或认知障碍患者血清同型半胱氨酸浓度较高,而败血症、白细胞增多症和低白蛋白血症患者浓度较低。营养不良与同型半胱氨酸浓度异常高和低均有关,同型半胱氨酸浓度异常低和异常高均与较高死亡率有关。总之,在未补充维生素的老年住院患者中,低同型半胱氨酸水平不应被解释为某些个体的保护因素。相反,它可能被认为是与预后不良相关的炎症-营养不良过程的一种效应。